Spots Global Cancer Trial Database for Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors
Official Title: A Phase I Clinical Study on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SHR-2002 Injection in Combination With SHR-1316 in Patients With Advanced Malignant Tumors
Study ID: NCT05082545
Conditions
Interventions
Study Description
Brief Summary: This is Phase 1 study FIH to check "Dose Escalation, Dose expansion and Indication expansion". This study is AUSTRALIA only study.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Icon Cancer Centre, Brisbane, Queensland, Australia
Linear clinical research, Perth, Western Australia, Australia
Scientia Clinical research, Sydney, , Australia
Liverpool Hospital, Sydney, , Australia
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
